The U.S. colonic stents market was valued at $6.44 million in 2018 and is projected to reach $9.41 million by 2026, registering a CAGR of 4.8% from 2019 to 2026.
The global colorectal cancer screening market was valued at $17.1 billion in 2023, and is projected to reach $25.6 billion by 2033, growing at a CAGR of 4.1% from 2024 to 2033.